NDC 54868-4087-0 - LEVOXYL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54868-4087
- Requested NDC
- 54868-4087-0
- Package NDCs from labels
- 54868-4087-1, 54868-4087-0
- Manufacturer
- Physicians Total Care, Inc.
- Effective date
- 2013-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levoxyl ® (levothyroxine sodium tablets, USP) | Physicians Total Care, Inc. | 2013-08-19 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54868-4087-1 | 2019-09-24 | C162847 | 48780-1 | 9350213a-44f6-c013-e053-90daa90a1393 | Levoxyl ® (levothyroxine sodium tablets, USP) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54868-4087-1 | LEVOXYL | 30 in 1 BOTTLE | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54868-4087 | LEVOXYL (LEVOTHYROXINE SODIUM) TABLET [PHYSICIANS TOTAL CARE, INC.] | 5 | 1 package rows | 20130820_951c6e16-7251-42ed-ac19-d8367a6aee4f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54868-4087-0 | EA - Each | 54868-4087 | 8e7eca2d-743f-4137-8bfc-afe5020aede8 | 1 | 2012-07-24 |
| 54868-4087-1 | EA - Each | 54868-4087 | c1593261-994c-4d69-8e10-1cbc0d542afa | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HEB Extra Strength Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | H. E. Butt Grocery Company | 9e502bd0-8042-8674-e053-2995a90a3d15 | 2023-12-18 | Warnings | 8MDF5V39QO |
| Medis Sodium Bicarbonate | SODIUM BICARBONATE | Humco Holding Group, Inc | 5da32469-58fc-14b1-e053-2a91aa0a74c4 | 2023-12-15 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 804d64c9-9804-4d6d-adb2-5036c0be8b5c | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 3e77de84-6f59-40ac-a1a4-7bfe30387823 | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| INON | ALUMINUM HYDROXIDE, MAGNESIUM CARBONATE, SODIUM BICARBONATE | Sato Pharmaceutical Co., Ltd. | e86d9c57-c877-49f1-a405-95a9a226ccf3 | 2023-12-04 | Warnings | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 89df6a0f-6602-4c22-a052-b565ea8368a7 | 2023-12-01 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 60a0bc29-4283-4ae9-9173-5caf9266f723 | 2023-11-16 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Sodium Bicarbonate | SODIUM BICARBONATE | A-S Medication Solutions | d89406d3-4356-4a8c-acc1-89efe1d27010 | 2023-11-14 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | 09cf38c2-0b44-eca1-e063-6294a90a72d8 | 2023-11-10 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 970b8456-5b9a-4839-9222-4ec1302266e2 | 2023-11-02 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| omeprazole sodium bicarbonate | OMEPRAZOLE SODIUM BICARBONATE | Cipla USA Inc. | 9cdde58a-ae8a-451f-92cf-cab178e4ba92 | 2023-11-01 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | APNAR PHARMA LP | e206c240-55c2-2d00-e053-2a95a90a1779 | 2023-10-21 | Boxed warning, Warnings | 8MDF5V39QO |
| Omeprazole/Sodium Bicarbonate | OMEPRAZOLE | Strides Pharma Science Limited | cf6d293e-d70d-443e-8292-d693e93aab55 | 2023-09-21 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 59762069-5ea7-43d9-ba5b-8b250767b146 | 2023-09-14 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | H3R47K3TBD |
| Sodium Bicarbonate | SODIUM BICARBONATE | OMNIVIUM PHARMACEUTICALS LLC. | aea54f8d-1cdd-4a5c-a2f7-7317ae4c8fbc | 2023-08-10 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Dr. Reddy's Laboratories Inc., | c6b5f808-4a49-1303-9711-badb022ecd70 | 2023-07-19 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | A-S Medication Solutions | 619cb558-84e5-43ea-91e9-28c764f9f9c0 | 2023-06-21 | Warnings, Adverse reactions | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.